Early research (Phase 1)WithdrawnNCT02953496
What this trial is testing
Safety/ Feasibility of Percutaneous Administration of Vonapanitase as Monotherapy for Peripheral Artery Disease (PAD) of the SFA and Popliteal Arteries
Who this might be right for
Peripheral Artery Disease
Proteon Therapeutics